Chips and Rate Hawks Drive Options Flow
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Semiconductor names are dominating both sides of the options tape. Micron Technology sits at the top of both bullish and bearish options bets over the past week — a split signal that points to big directional uncertainty ahead of its Q4 results. The stock is up 236% year-to-date. Options traders are positioning hard, but they are not agreeing on which way it goes.
NVIDIA is drawing heavy bearish flows despite a fresh narrative calling it the AI boom's "buyer of last resort." Its short score sits at just 29. Sentiment in the options market tells a more cautious story. Advanced Micro Devices also appears in top negative bets. Its RSI has dropped to 42.75, suggesting the recent 113% YTD run may be running out of steam.
On the macro side, Fed Governor Hammack flagged inflation remains too high. She went further — suggesting policy is not yet restrictive and a rate hike may be warranted. That comment hit broad market sentiment hard. It adds pressure to any rate-sensitive positions heading into the weekend.
lululemon athletica is drawing put-side attention after Truist reiterated its Sell rating and cut its price target to $82. The stock is already down 41% year-to-date. Options flow there looks defensive.
Boston Scientific jumped into focus after announcing a spinal cord stimulator recall over fracture risk. That kind of headline typically triggers a spike in near-term put volume as traders hedge event-driven downside.
The options landscape this week points to one clear theme: semi stocks carry the most unresolved tension. Where Micron goes next may set the tone.
Stocks in this article
How this article was generated
- Generated
- 4 Sept 2026, 16:50
- Prompt version
- v1.0
- Data sources
- Options flowORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.